Primary Myelofibrosis

Showing NaN - NaN of 15

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

Recruiting
  • Primary Myelofibrosis
  • +2 more
  • Birmingham, Alabama
  • +151 more
Aug 22, 2022

Myeloproliferative Disorders, Myelofibrosis, Primary Myelofibrosis Trial in Worldwide (ACE-536, Placebo)

Recruiting
  • Myeloproliferative Disorders
  • +4 more
  • La Jolla, California
  • +184 more
Aug 22, 2022

Primary Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia Trial in Toronto (Observational)

Recruiting
  • Primary Myelofibrosis
  • +9 more
  • Observational
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 11, 2022

Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

Active, not recruiting
  • Primary Myelofibrosis
  • +2 more
  • Phoenix, Arizona
  • +166 more
Jan 27, 2022

Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

Terminated
  • Primary Myelofibrosis
  • +2 more
  • Scottsdale, Arizona
  • +121 more
Oct 21, 2021

Primary Myelofibrosis, Thrombocytosis, Essential Thrombocythemia Trial in Worldwide (LDE225, INC424)

Completed
  • Primary Myelofibrosis
  • +9 more
  • Camperdown, New South Wales, Australia
  • +17 more
Apr 3, 2020

Primary Myelofibrosis, MPN-associated Myelofibrosis Trial in Worldwide (Pomalidomide 0.5 mg, Placebo, Pomalidomide)

Completed
  • Primary Myelofibrosis
  • MPN-associated Myelofibrosis
  • Pomalidomide 0.5 mg
  • +2 more
  • Scottsdale, Arizona
  • +86 more
Jun 24, 2019

Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis Trial in Canada,

Terminated
  • Primary Myelofibrosis
  • +2 more
  • Ruxolitinib Pre- Hematopoietic cell transplantation (HCT)
  • Atlanta, Georgia
  • +7 more
Feb 28, 2019